Search

everythinglearnresearchcommunity

for

Search:↓

Adults are more reactive to allergens than older adults, who are more sensitive to medication-related allergens.

ILC1 cells contribute to hair loss in alopecia areata.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Mogamulizumab can cause hair loss and skin rashes.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Immune cells might contribute to hair loss caused by a specific mutation.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Hair from balding and non-balding areas regrows similarly on mice.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Tinea capitis should be considered for scalp infections in infants.

A new one-step test can quickly identify skin cancer during surgery.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Six months after COVID-19, most patients still had autoantibodies.

Basal cell carcinoma cases are rising globally.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

PRAME helps distinguish between benign and malignant skin cells in most cases.

No link found between Coxsackie viruses and pemphigus.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.